Scarica l'app Stockscreener
15.38
4.20%
0.62
Pre-mercato:
15.42
0.04
+0.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVTR Giù?
Forum
Previsione
Precedente Chiudi:
$14.76
Aprire:
$14.72
Volume 24 ore:
7.72M
Relative Volume:
0.81
Capitalizzazione di mercato:
$10.40B
Reddito:
$6.55B
Utile/perdita netta:
$-551.40M
Rapporto P/E:
-19.03
EPS:
-0.8082
Flusso di cassa netto:
$438.90M
1 W Prestazione:
-3.03%
1M Prestazione:
+7.85%
6M Prestazione:
+98.97%
1 anno Prestazione:
+28.06%
Intervallo 1D:
$14.67
$15.43
Intervallo di 1 settimana:
$14.67
$15.90
Portata 52W:
$7.265
$16.05
Avantor Inc Stock (AVTR) Company Profile
Nome
Avantor Inc
Settore
Industria
Telefono
(610) 386-1700
Indirizzo
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, RMD, ALC, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
15.38 | 10.40B | 6.55B | -551.40M | 438.90M | -0.8082 |
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Downgrade | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Downgrade | Jefferies | Hold → Underperform |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-11-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-29 | Downgrade | Goldman | Buy → Neutral |
| 2025-04-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-04-28 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-17 | Downgrade | UBS | Buy → Neutral |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-10-05 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-09-14 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-09-09 | Downgrade | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-30 | Ripresa | Raymond James | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-08-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Iniziato | Goldman | Buy |
| 2021-04-29 | Aggiornamento | Stifel | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-08-02 | Iniziato | Cleveland Research | Neutral |
| 2019-06-14 | Iniziato | Janney | Buy |
| 2019-06-12 | Iniziato | Raymond James | Outperform |
| 2019-06-11 | Iniziato | Goldman | Buy |
| 2019-06-11 | Iniziato | Guggenheim | Buy |
| 2019-06-11 | Iniziato | JP Morgan | Overweight |
| 2019-06-11 | Iniziato | Jefferies | Buy |
| 2019-06-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-06-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-11 | Iniziato | SunTrust | Buy |
| 2019-06-11 | Iniziato | UBS | Buy |
| 2019-06-11 | Iniziato | William Blair | Outperform |
Mostra tutto
Avantor Inc Borsa (AVTR) Ultime notizie
A Look at Avantor Inc (AVTR) After 4.2% Gain -- GF Value $16.87 vs Price $15.38 - GuruFocus
Avantor stock falls 1.20 percent as new CFO takes office - AD HOC NEWS
Avantor, Inc. (AVTR) Stock Forecasts - finance.yahoo.com
Form 4 Avantor Inc For: 23 September By Investing.com - Investing.com Canada
At $16.61 a share, Avantor (AVTR) grants its CFO options that begin vesting in 2027. - Stock Titan
[Form 3] Avantor, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out - ACCESS Newswire
How Avantor’s New CFO Appointment At Avantor (AVTR) Has Changed Its Investment Story - Yahoo Finance
Avantor Appoints Todd Garner as New Chief Financial Officer - The Globe and Mail
Avantor stock reacts as new CFO Todd Garner steps in - AD HOC NEWS
Form 8K Avantor Inc For: 21 September By Investing.com - Investing.com Nigeria
Avantor (NYSE: AVTR) Appoints Todd Garner as CFO with $700K Salary and $1.5M Equity Award - Kalkine Media
Avantor Appoints Todd Garner as Executive Vice President and CFO with Detailed Compensation Package - Kalkine Media
Are Medical Stocks Lagging Avantor (AVTR) This Year? - finance.yahoo.com
Avantor Names Todd Garner CFO to Lead Global Finance Organization - citybiz
Avantor names Todd Garner as chief financial officer By Investing.com - Investing.com Australia
Avantor Appoints New Chief Financial Officer - TradingView
Avantor, Inc. Appoints Todd Garner as Executive Vice President Effective September 21, 2026 - marketscreener.com
Avantor (AVTR) hires new CFO with seven-figure stock grants - Stock Titan
Avantor Names Todd Garner as CFO - finance.yahoo.com
Avantor names Todd Garner as new CFO to lead gl... - Pluang
Avantor names Todd Garner as chief financial officer - Investing.com
Avantor appoints new Chief Financial Officer - AOL.ca
Avantor (AVTR) Appoints New Chief Financial Officer - TradingView
Avantor, Inc. (AVTR) Stock Analysis: Navigating Opportunities In The Healthcare Sector - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy? - Eastern Progress
Avantor Stock Price Forecast. Should You Buy AVTR? - StockInvest.us
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC - finance.yahoo.com
Avantor Inc (AVG) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Avantor expands RIM single-use portfolio of bioprocessing solutions across APAC - BioSpectrum Asia
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
Avantor Inc stock hits 52-week high at 15.94 USD By Investing.com - Investing.com Nigeria
Avantor Inc stock hits 52-week high at 15.94 USD - Investing.com
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Avantor, Inc. (NYSE:AVTR) Expands RIM Single-Use Portfolio Across APAC - TradingView
Here's Why You Should Add Avantor Stock to Your Portfolio for Now - Zacks Investment Research
Avantor Stock Has Strong Technical Momentum, But Make Sure Your Stop Losses Are Tight - Yahoo Finance
Avantor, Inc. (AVTR) Stock Analysis: Navigating a Competitive Healthcare Landscape with Cautious Optimism - directorstalkinterviews.com
ETFs Investing in Avantor, Inc. Stocks - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
(AVTR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
UBS Adjusts Avantor Price Target to $16 From $10.50, Maintains Neutral Rating - finance.yahoo.com
Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Landscape with a Forward P/E of 16.98 - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out - accessnewswire.com
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out | NYSE:AVTR | Press Release - Stockhouse
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Avantor stock gains as investors focus on recent earnings and valuation - AD HOC NEWS
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised - Eastern Progress
Is It Too Late to Buy Avantor Inc (AVTR) After 3.2% Rally? GF Va - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect - ACCESS Newswire
Avantor Inc Azioni (AVTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
3.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):